Latest
Daily Tech Times Subscribe

Spin-outs from UK universities: how research becomes an AI or deep-tech startup

Around 2,000 companies have spun out of UK universities since 2010, and deep-tech fields including AI now account for 96% of the value those companies have gone on to create.

Yellow and green cables are neatly connected
Photo · Photo by Albert Stoynov on Unsplash

A university spin-out is a company formed to commercialise research or intellectual property developed inside a university, typically with the university itself taking an equity stake in exchange for licensing that IP to the new business. Around 2,000 spin-outs have been created from UK universities since 2010, and according to the Royal Academy of Engineering’s Spotlight on Spinoutsundefinedreport, published in June 2026, those companies have generated 27,000 jobs, 70% of them created since 2020, and deep-tech fields, principally life sciences, AI and quantum technology, now account for 96% of the total value those spin-outs have created. For a founder or researcher weighing whether spinning a piece of academic work out into a company is realistic, understanding how the process actually works, and where it tends to go wrong, matters more than the headline growth numbers.

What actually makes a piece of research a candidate for a spin-out?

Research becomes spin-out material when it produces intellectual property, a novel algorithm, a piece of hardware, a dataset or technique, that has commercial value beyond the academic paper it was published in, and where a university’s technology transfer office (TTO) judges that a standalone company is the best route to get it into real-world use. The process typically starts with a researcher disclosing an invention to their university’s TTO, which then assesses its commercial potential, decides whether to seek patent protection, and negotiates the terms on which the new company will be allowed to use the underlying IP. Not every piece of promising research becomes a spin-out: many are licensed instead to an existing company, and a spin-out is generally only pursued where the university judges that a new, dedicated company is a better route to commercialisation than licensing the technology to somebody else.

How does equity actually get split between the university, founders and investors?

The university typically takes an equity stake in the new company in exchange for the licence to use the underlying IP, and the size of that stake has been falling, the Spotlight on Spinoutsundefinedreport found average university equity stakes have dropped to 16%, the lowest level in the past decade, reflecting a broader push, including from the government-commissioned Hickson Review, to make university spin-out terms more competitive with what founders could get starting a company from scratch. How the remaining equity is split among the founding academics themselves varies significantly: the same report found 63% of successful spin-outs used unequal splits between founders (reflecting different levels of contribution or ongoing involvement) against 34% that split founder equity equally, and that only 17% of UK spin-outs have at least one female founder, with 83% remaining all-male founding teams.

What does university spin-out equity typically look like?

Metric Figure
Average university equity stake (2026) 16%, lowest in the past decade
Spin-outs with unequal founder equity splits 63%
Spin-outs with equal founder equity splits 34%
Spin-outs with at least one female founder 17%

What is the Hickson Review, and why does it matter for spin-out founders?

The Hickson Review, a government-commissioned assessment of university-investor links authored by Tony Hickson and published in February 2026, examined why UK spin-outs have historically struggled to scale despite the country’s research strength, and recommended a series of reforms including exploring shared technology transfer offices between universities, expanding proof-of-concept and pre-seed funding, and improving the visibility and continuity of funding pathways for early spin-outs. A separate Research England pilot, which ran from Novemberundefinedto Aprilundefinedand awarded £4.74m acrossundefinedprojects through the Connecting Capability Fund, tested the shared-TTO model directly: it produced six spin-outs, advancedundefinedcommercial opportunities, and brought togetherundefinedpartner organisations including universities, law firms, angel investors and hospitals, evidence the government has pointed to in pushing smaller universities toward pooling TTO resources rather than each running a standalone office.

How much value are UK university spin-outs actually generating?

The combined enterprise value of UK university spin-outs has grown 2.8-fold since 2020, reaching a total of £49bn, with more than 75% of that value still held in private, non-acquired companies and £40bn, 80% of the total, sitting in spin-outs still headquartered in the UK. The concentration in deep tech is stark: 96% of total spin-out value now sits in life sciences, AI and quantum technology companies, and five UK universities, Oxford, Cambridge, UCL, Bristol and Imperial College London, rank among the top ten spin-out-value-generating universities in Europe. Oxford alone produced two of Europe’s six billion-dollar-plus spin-out exits in 2025: OrganOx, a medical device company, was acquired for around $1.5bn, and Oxford Ionics, a quantum technology company, sold for around $1.1bn.

What does the actual path from lab to company look like?

After a researcher discloses an invention and the university’s TTO decides to pursue a spin-out, the typical path runs through securing initial proof-of-concept or pre-seed funding, often from university-affiliated seed funds, Innovate UK grants or specialist deep-tech investors, formally incorporating the company and finalising the IP licence and university equity stake, and then raising a first proper funding round, frequently from investors who specialise in university spin-outs and understand the longer development timelines common in deep tech. This process is generally slower than a typical commercial startup’s path to first funding, since deep-tech spin-outs often need to prove a scientific or technical result works outside the lab before they can raise meaningfully, which is part of why the government reforms recommended by the Hickson Review focus heavily on expanding proof-of-concept and pre-seed funding specifically.

What should a researcher considering a spin-out actually check first?

A researcher weighing whether to pursue a spin-out should check their university’s IP and spin-out policy early, since the terms on which the university will license the underlying IP and the size of equity stake it will take vary between institutions and materially affect what is left for founders. It is also worth establishing early, ideally before public disclosure or publication of the underlying research, whether the invention is genuinely patentable and whether any of the work was jointly funded or co-developed with another institution or industry partner, since unresolved IP ownership questions are one of the most common reasons a promising spin-out stalls before it properly starts.

The practical takeaway

The data shows UK university spin-outs, and deep-tech spin-outs in AI, life sciences and quantum in particular, generating genuinely large and growing value, but the path from research to funded company still runs through a slower, more specialised process than a typical commercial startup, and the terms agreed with the university’s TTO at the outset shape everything that follows. A researcher considering this route should engage their university’s TTO as early as possible, understand the specific IP and equity terms on offer before committing to anything, and, given the reforms already underway following the Hickson Review, ask directly whether their institution is part of a shared TTO arrangement or has adopted any of the recommended changes to pre-seed funding and equity terms.

Sources